Skip to main content
. 2021 Apr 16;11:659676. doi: 10.3389/fonc.2021.659676

Figure 6.

Figure 6

ML-098 partly reversed the reduction in numbers of S phase cells in the Lv-HNRNPC group. (A, B) Cell cycle analysis to detect the recovery of numbers of S phase cells in the Lv-HNRNPC groups after treatment with ML-098. (C, D) Western blot to detect the recovery of c-Myc, CDK4, and cyclin E1 in Lv-HNRNPC cell groups after treatment with ML-098. All tests were repeated independently in triplicate, and the results were showed as mean ± standard deviation (SD). *P < 0.05, **P < 0.01, ***P < 0.001, for Lv-NC+DMSO group compared with Lv-HNRNPC+ML-098 group; #P < 0.05, ##P < 0.01, ###P < 0.001, for Lv-HNRNPC+DMSO group compared with Lv-HNRNPC+ML-098 group.